Chemed EBITDA 2010-2025 | CHE

Chemed EBITDA for the quarter ending March 31, 2025 was $0.111B, a 25.66% increase year-over-year.

  • Chemed 2024 EBITDA was 0.43B, a 6.93% increase from 2023.
  • Chemed 2023 EBITDA was 0.402B, a 0.25% decline from 2022.
  • Chemed 2022 EBITDA was 0.403B, a 0.15% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Chemed EBITDA 2010-2025 | CHE

  • Chemed 2024 EBITDA was 0.43B, a 6.93% increase from 2023.
  • Chemed 2023 EBITDA was 0.402B, a 0.25% decline from 2022.
  • Chemed 2022 EBITDA was 0.403B, a 0.15% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$18.3B
DaVita (DVA)$11.2B
Encompass Health (EHC)$10.4B
Option Care Health (OPCH)$5.3B
Elanco Animal Health (ELAN)$4.2B
RadNet (RDNT)$3.7B
Amedisys (AMED)$3B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$1.8B
Astrana Health (ASTH)$1.6B
U.S Physical Therapy (USPH)$1B
Pennant (PNTG)$907M
Aveanna Healthcare Holdings (AVAH)$886M
Atai Life Sciences (ATAI)$294M
Daxor (DXR)$36M
Ontrak (OTRK)$6M
MEDIROM Healthcare Technologies (MRM)$4M
Psychemedics (PMD)$0M